Ignite Creation Date:
2024-05-05 @ 12:11 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00262574
Status:
UNKNOWN
Last Update Posted:
2011-08-09
First Post:
2005-12-06
Brief Title:
Effect of BNP Brain Natriuretic Peptides on Endothelial Dysfunction Induced by Coronary Angioplasty
Sponsor:
The Baruch Padeh Medical Center Poriya
Organization:
The Baruch Padeh Medical Center Poriya
Study Overview
Official Title:
Phase 4 Study of Patients Receiving BNP or NTG IV During Angioplasty Re-examined 24 Hours Later Using the Flow-mediated Brachial Artery Dilation Study and Blood Assays for Pro BNP and ET1
Status:
UNKNOWN
Status Verified Date:
2010-12
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Patients receiving BNP or nitroglycerin IV during the angioplasty procedure 24 h after the procedure vascular reactivity will be re-examined using the brachial artery flow-mediated dilatation study Blood assays for ET-1 pro-BNP and various inflammatory markers will be checked before and 24 h after the procedure It is our hypothesis that endothelial function will be better in the BNP treated patients compared to the NTG treated patients
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None